Leucine-rich repeat-containing protein 75B, commonly abbreviated as LRRC75B, is part of the leucine-rich repeat (LRR) protein family, which is characterized by a repetitive sequence motif that is rich in the amino acid leucine. This motif typically consists of 20-29 amino acid residues and forms a structural domain that facilitates protein-protein interactions. These interactions are essential for the assembly of many different types of protein complexes and are involved in various cellular processes, including signal transduction, cell adhesion, and immune responses.
The LRRC75B protein, like other members of this family, is likely to have a horseshoe-shaped structure that the LRR domains form. This structure provides a versatile scaffold for protein-ligand interactions. The specific functions of LRRC75B can include roles in cellular signaling, neuronal development, and possibly the modulation of specific pathways related to the immune system or development.The "leucine-rich" aspect of its name refers to the presence of leucine, which is a hydrophobic amino acid that often contributes to the formation of stable, non-covalent interactions important for the protein's tertiary structure. This structure can allow LRRC75B to participate in specific protein-protein interactions, potentially influencing signal transduction pathways by binding to other proteins, such as receptors, enzymes, or structural proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can impact protein synthesis and potentially influence LRRC75B functions. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporine A inhibits calcineurin, affecting signal transduction pathways that could indirectly influence LRRC75B. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Wnt signaling is often mediated by LRR-containing proteins; inhibitors like IWP-2 may indirectly affect LRRC75B-related pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, potentially impacting protein degradation processes relevant to LRRC75B. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
HSP90 is crucial for protein folding; its inhibitors may affect the stability and function of LRRC75B. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB signaling can involve LRR proteins; inhibitors like BAY 11-7082 may indirectly impact LRRC75B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibitors of the PI3K/Akt pathway might influence signaling pathways relevant to the function of LRRC75B. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
The MAPK/ERK pathway is involved in various cellular processes; inhibitors might affect pathways associated with LRRC75B. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Inhibiting JAK/STAT signaling might indirectly influence LRRC75B activity if it's involved in related pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-β signaling involves LRR proteins; inhibitors could affect LRRC75B if it's part of related pathways. |